The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma

Biomaterials

Volumn 31, Issue 20, 2010, Pages 5325-5335

  Zhou, Yongsheng ^a   Ni, Yongwei ^a   Liu, Yunsong ^a   Zeng, Baijin ^a   Xu, Yongwei ^a   Ge, Wenshu ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

Adipose derived stromal cells; Bone tissue engineering; Critical sized calvarial defects; Injectable bone; Platelet rich plasma; Simvastatin

Indexed keywords

ADIPOSE-DERIVED STROMAL CELLS; BONE TISSUE ENGINEERING; CALVARIAL DEFECTS; CRITICAL-SIZED CALVARIAL DEFECTS; PLATELET RICH PLASMA; SIMVASTATIN;

BIOACTIVITY; BLOOD SUBSTITUTES; CELL CULTURE; CELL PROLIFERATION; DEFECTS; GENE EXPRESSION; MINERALOGY; OPTIMIZATION; PEPTIDES; PHOSPHATASES; PLASMAS; PLATELETS; TISSUE ENGINEERING;

BONE;

ALKALINE PHOSPHATASE; ANABOLIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN 2; EOSIN; HEMATOXYLIN; OSTEOCALCIN; SIMVASTATIN; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ADIPOSE TISSUE CELL; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL DEFECT; STROMA CELL; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; X RAY ANALYSIS;

ADIPOSE TISSUE; ALKALINE PHOSPHATASE; ANIMALS; BONE MATRIX; CALCIFICATION, PHYSIOLOGIC; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; GENE EXPRESSION REGULATION; HUMANS; INJECTIONS; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PLATELET-RICH PLASMA; SIMVASTATIN; SKULL; STAINING AND LABELING; STROMAL CELLS; TISSUE ENGINEERING; YOUNG ADULT;

MUS;

EID: 77952582559     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.03.037     Document Type: Article

References (35)

1. Liu Y., Zhou Y., Feng H., Ma G., Ni Y. Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plasma. Biomaterials 2008, 29:3338-3345.
2. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
3. 3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro?. Chin Med J (Engl) 2006, 119:1278-1286.
4. Kocaoemer A., Kern S., Klüter H., Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007, 25:1270-1278.
5. Ito K., Yamada Y., Nagasaka T., Baba S., Ueda M. Osteogenic potential of injectable tissue engineered bone: a comparison among autogenous bone, bone substitute (Bio-Oss), platelet-rich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res 2005, 73A:63-72.
6. Anitua E., Sánchez M., Nurden A.T., Nurden P., Orive G., Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006, 24:227-234.
7. Yamada Y., Ueda M., Naiki T., Takahashi M., Hata K., Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 2004, 10:955-964.
8. Yamada Y., Ueda M., Hibi H., Nagasaka T. Translational research for injectable tissue engineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. Cell Transplant 2004, 13:343-355.
9. Kitoh H., Kitakoji T., Tsuchiya H., Mitsuyama H., Nakamura H., Katoh M., et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis: a preliminary result of three cases. Bone 2004, 35:892-898.
10. Wang C.K., Ho M.L., Wang G.J., Chang J.K., Chen C.H., Fu Y.C., et al. Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials 2009, 30:4178-4186.
11. Benglis D., Wang M.Y., Levi A.D. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 2008, 62:ONS 423-431.
12. Chen N.F., Smith Z.A., Stiner E., Armin S., Sheikh H., Khoo L.T. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. J Neurosurg Spine 2010, 12:40-46.
13. Peterson B., Zhang J., Iglesias R., Kabo M., Hedrick M., Benhaim P., et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005, 11:120-129.
14. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999, 286:1946-1949.
15. Uzzan B., Cohen R., Nicolas P., Cucherat M., Perret G.Y. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 2007, 40:1581-1587.
16. Pauly S., Luttosch F., Morawski M., Haas N.P., Schmidmaier G., Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone 2009, 45:505-511.
17. Baek K.H., Lee W.Y., Oh K.W., Tae H.J., Lee J.M., Lee E.J., et al. The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells. J Korean Med Sci 2005, 20:438-444.
18. Maeda T., Matsunuma A., Kawane T., Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001, 280:874-877.
19. Maeda T., Matsunuma A., Kurahashi I., Yanagawa T., Yoshida H., Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 2004, 92:458-471.
20. Ruiz-Gaspa S., Nogues X., Enjuanes A., Monllau J.C., Blanch J., Carreras R., et al. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem 2007, 101:1430-1438.
21. Song C., Guo Z., Ma Q., Chen Z., Liu Z., Jia H., et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003, 308:458-462.
22. Sonobe M., Hattori K., Tomita N., Yoshikawa T., Aoki H., Takakura Y., et al. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture. Biomed Mater Eng 2005, 15:261-267.
23. Kupcsik L, Meury T, Flury M, Stoddart M, Alini M. Statin-induced calcification in human mesenchymal stem cells is cell-death related. J Cell Mol Med. Postprint 10.1111/j.1582-4934.2008.00545.x.
24. Aubin J.E., Triffitt J.T. Mesenchymal stem cells and osteoblast differentiation. The principles of bone biology 2002, 59-82. Academic Press, San Diego. 2nd ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
25. Benoit D.S., Nuttelman C.R., Collins S.D., Anseth K.S. Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 2006, 27:6102-6110.
26. Weis M., Heeschen C., Glassford A.J., Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 2002, 105:739-745.
27. Wong R.W., Rabie A.B. Early healing pattern of statin-induced osteogenesis. Br J Oral Maxillofac Surg 2005, 43:46-50.
28. Bouletreau P.J., Warren S.M., Spector J.A., Peled Z.M., Gerrets R.P., Greenwald J.A., et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 2002, 109:2384-2397.
29. Choi K.Y., Kim H.J., Lee M.H., Kwon T.G., Nah H.D., Furuichi T., et al. Runx2 regulates FGF2-induced BMP-2 expression during cranial bone development. Dev Dyn 2005, 233:115-121.
30. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002, 143:1545-1553.
31. Lee Y., Schmid M.J., Marx D.B., Beatty M.W., Cullen D.M., Collins M.E., et al. The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials 2008, 29:1940-1949.
32. Jadhav S.B., Jain G.K. Statins and osteoporosis: new role for old drugs. J Pharm Pharmacol 2006, 58:3-18.
33. Serin-Kilicoglu S., Erdemli E. New addition to the statin's effect. J Trauma 2007, 63:187-191.
34. Kiliç E., Ozeç I., Yeler H., Korkmaz A., Ayas B., Gümüş C. Effects of simvastatin on mandibular distraction osteogenesis. J Oral Maxillofac Surg 2008, 66:2233-2238.
35. Morris M.S., Lee Y., Lavin M.T., Giannini P.J., Schmid M.J., Marx D.B., et al. Injectable simvastatin in periodontal defects and alveolar ridges: pilot studies. J Periodontol 2008, 79:1465-1473.